LIVAMIN
L-ISOLEUCINE L-LEUCINE L-LYSINE L-MALEATE L METHIONINE L- PHENYLALANINE L- THREONINE L-THYPTOPHAN L- VALINE L-ARGININE L-HISTIDINE L-ORNITHINE L-ASPARTATE L-ALANINE N-ACETYL L-CYSTEINE L-GLUTAMIC ACID GLYCINE L-PROLINE L-SE
What it does
Glycine is an amino acid that plays a role in various bodily functions.
Commonly used for: supporting mood and mental health, helping with sleep issues, aiding muscle recovery
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:06:46 · updated 2026-03-23 04:51:55
About glycine
Glycine is an amino acid that plays a role in various bodily functions.
What it treats
- supporting mood and mental health
- helping with sleep issues
- aiding muscle recovery
How it works
Glycine helps to build proteins in the body and can have a calming effect on the brain.
Who it's for
Glycine may be suitable for adults looking to improve their mood, sleep, or muscle recovery.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About methionine
Methionine is an amino acid that plays a role in various body functions, including making proteins and supporting metabolism.
What it treats
- liver disease
- certain types of depression
- cognitive disorders
How it works
Methionine helps in the production of important substances in the body, such as proteins and antioxidants.
Who it's for
Methionine may be used by adults and children who need support for liver health or specific mental health conditions.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About phenylalanine
Phenylalanine is an amino acid that helps in the production of proteins in the body.
What it treats
- Phenylketonuria (PKU)
- Dietary supplement
How it works
Phenylalanine is used by the body to create proteins, which are important for growth and repair of tissues.
Who it's for
This is mainly for people with phenylketonuria (PKU) who need to manage their phenylalanine levels.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About threonine
Threonine is an amino acid that is important for the body's protein production.
What it treats
- supporting protein synthesis
- promoting muscle growth
- aiding in the production of antibodies
How it works
Threonine helps the body build proteins which are essential for various functions including muscle development and immune response.
Who it's for
Threonine is suitable for individuals needing extra support in protein intake, such as athletes or those with specific dietary needs.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About valine
Valine is an essential amino acid that the body needs for growth and tissue repair.
What it treats
- muscle recovery
- supporting immune function
How it works
Valine helps build proteins and is important for energy production in muscles.
Who it's for
This is for individuals needing extra support for muscle health or recovery, especially athletes.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: Glycine
BNF-referencedGlycine is a non-essential amino acid that plays a significant role in various physiological processes, including neurotransmission and immune function. It acts as an inhibitory neurotransmitter in the central nervous system by binding to specific receptors. Glycine is also involved in the synthesis of proteins, hormones, and other biomolecules, contributing to metabolic processes. In clinical practice, glycine is primarily used in irrigation solutions during urological surgeries.
Indications
- Bladder irrigation during urological surgery
- Irrigation for transurethral resection of the prostate gland
- Irrigation for bladder tumors
Dosage
Children: Refer to the BNF for Children for pediatric dosing guidelines.
Adults: Refer to the product literature for specific dosing information.
Mechanism of action
Glycine binds to strychnine-sensitive and strychnine-insensitive glycine receptors in the central nervous system. The strychnine-sensitive receptor is a chloride channel that enhances inhibitory neurotransmission. This action may contribute to glycine's potential antispastic effects. Additionally, glycine potentiates NMDA receptor-mediated neurotransmission, which may have implications in managing certain neurological conditions, such as neuroleptic-resistant negative symptoms in schizophrenia.
Pharmacodynamics
Glycine plays a crucial role in various biological functions, including energy metabolism and immune response. It is involved in hormone synthesis and helps in modulating neurotransmitter release, particularly in inhibitory pathways. Glycine's ability to enhance chloride conductance in neurons contributes to its antispastic properties and its potential to mitigate oxidative stress in immune responses.
Pharmacokinetics
Glycine is absorbed readily in the gastrointestinal tract and is utilized by the body for protein synthesis and other metabolic functions. The distribution of glycine in the body is widespread, as it is present in various tissues. Glycine is metabolized in the liver and other tissues, with excretion primarily occurring via the kidneys. The pharmacokinetics of glycine can be influenced by factors such as age, renal function, and overall health status.
Adverse effects
- Fluid overload
- Electrolyte imbalance
- Nausea
- Vomiting
- Headache
- Hypotension
Precautions
- Monitor for signs of fluid overload during irrigation
- Use caution in patients with pre-existing electrolyte imbalances
- Careful consideration in patients with renal impairment
Pregnancy
Glycine is generally considered safe for use during pregnancy when used as an irrigation solution, but risks should be discussed with a healthcare provider.
Breast-feeding
Glycine is likely safe during breastfeeding, but limited data is available. Consultation with a healthcare professional is advisable.
Storage
Store in a cool, dry place. Protect from light. Do not freeze.
Formulations
- Glycine 1.5% irrigation solution 3 litre Easyflow bags
- Glycine 1.5% irrigation solution 1 litre Flowfusor bottles
- Glycine 1.5% irrigation solution 1 litre Easyflow bags
- Glycine 1.5% irrigation solution 2 litre Flowfusor bottles
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: methionine
BNF-referencedMethionine is an essential amino acid that plays a critical role in various metabolic processes, including protein synthesis, detoxification, and antioxidant defense. It serves as a precursor to other important biomolecules, including L-cysteine and S-adenosylmethionine, contributing to cellular functions such as methylation and sulfur metabolism. Methionine is also involved in the synthesis of lecithin, which is significant for liver health and cholesterol metabolism. Additionally, methionine has potential protective effects against hepatotoxic agents, including acetaminophen.
Indications
- Methionine deficiency
- Hepatotoxicity prevention
- Cholesterol management
Mechanism of action
The mechanism of the possible anti-hepatotoxic activity of L-methionine is not entirely clear. It is thought that metabolism of high doses of acetaminophen in the liver leads to decreased levels of hepatic glutathione and increased oxidative stress. L-methionine serves as a precursor to L-cysteine, which has antioxidant properties and is a precursor to glutathione. The antioxidant activity of L-methionine and its metabolites likely contribute to its potential anti-hepatotoxic effects. Methionine also exhibits free-radical scavenging activity and chelating ability due to its sulfur content.
Pharmacodynamics
L-Methionine functions as a primary supplier of sulfur, which is essential for preventing hair, skin, and nail disorders. It aids in lowering cholesterol levels by enhancing the liver's production of lecithin, reducing liver fat, and protecting kidney function. Methionine acts as a natural chelating agent for heavy metals and helps regulate ammonia formation, contributing to ammonia-free urine and reduced bladder irritation. Furthermore, it influences hair follicles and promotes hair growth, in addition to its potential protective effects against hepatotoxins like acetaminophen.
Pharmacokinetics
Methionine is absorbed from the gastrointestinal tract and is distributed throughout the body, where it is utilized in protein synthesis and converted into other metabolites, such as S-adenosylmethionine and L-cysteine. The metabolism of methionine involves several pathways, including transsulfuration to cysteine and incorporation into proteins. The renal clearance of methionine is significant, as it is involved in the regulation of nitrogen balance and the formation of ammonia.
Adverse effects
- Nausea
- Vomiting
- Abdominal pain
- Allergic reactions
Precautions
- Use with caution in patients with liver disease
- Monitor for allergic reactions in sensitive individuals
Pregnancy
There is insufficient evidence to determine the safety of methionine during pregnancy. Consult a healthcare provider before use.
Breast-feeding
It is not known whether methionine is excreted in human milk. Caution is advised when administering to breastfeeding women.
Storage
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Formulations
- Oral tablets
- Powder for oral solution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: phenylalanine
BNF-referencedPhenylalanine is an essential amino acid that plays a vital role in the synthesis of proteins and the production of important neurotransmitters, including norepinephrine and dopamine. It is implicated in various physiological processes, including mood regulation, cognitive function, and the stimulation of melanin production in the skin. Due to its significance in neurotransmitter synthesis, phenylalanine may hold potential therapeutic benefits for conditions such as depression and vitiligo.
Indications
- Depression
- Cognitive deficits
- Attention Deficit Hyperactivity Disorder (ADHD)
- Vitiligo
Dosage
Children: Refer to the BNF for Children for age-appropriate dosing.
Adults: Refer to the BNF for specific dosing guidelines.
Mechanism of action
The antidepressant effects of L-phenylalanine are thought to arise from its role as a precursor in synthesizing norepinephrine and dopamine. These neurotransmitters are associated with mood elevation and cognitive enhancement. Additionally, L-phenylalanine may stimulate melanin production, although the exact mechanism for this activity is not well understood. The amino acid is involved in protein synthesis through its interaction with transfer RNA (tRNA) and messenger RNA (mRNA), facilitating the translation process essential for generating specific proteins.
Pharmacodynamics
L-phenylalanine is utilized by the brain to produce norepinephrine, a neurotransmitter that enhances alertness, reduces hunger, and may exhibit antidepressant properties. Its influence on neurotransmitter levels is crucial for maintaining mood and cognitive functions, while also potentially improving memory and overall mental clarity.
Pharmacokinetics
Phenylalanine is absorbed from the gastrointestinal tract and is transported to various tissues, where it is incorporated into proteins or converted to other compounds, such as tyrosine. The metabolism of phenylalanine involves its conversion via the enzyme phenylalanine hydroxylase, which transforms it into tyrosine, a precursor for neurotransmitters. The elimination half-life and excretion pathway details remain unspecified, with further research required to delineate these aspects.
Pregnancy
There are no well-controlled studies in pregnant women, hence phenylalanine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Breast-feeding
L-phenylalanine is excreted in breast milk. Caution is advised when administering to nursing mothers.
Storage
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Formulations
- L-Phenylalanine tablets
- L-Phenylalanine capsules
- L-Phenylalanine powder
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: threonine
BNF-referencedThreonine is an essential amino acid that plays a crucial role in several metabolic processes within the body. It is a precursor to glycine and serine and is important for maintaining protein balance. Threonine supports the formation of collagen, elastin, and tooth enamel, contributing to proper growth and repair of tissues. It also aids in liver function and helps in preventing fat accumulation in the liver, thus acting as a lipotropic agent.
Indications
- Essential amino acid supplementation
- Support for liver function
- Improvement of protein synthesis
- Support in the formation of collagen and elastin
- Aid in digestive health
Dosage
Children: Refer to BNF for Children for appropriate dosage guidelines.
Adults: Refer to BNF for appropriate dosage guidelines.
Mechanism of action
L-Threonine acts as a precursor to the amino acids glycine and serine. It aids in protein synthesis by binding with transfer RNA (tRNA) in the cytoplasm, facilitating the translation of messenger RNA (mRNA) into specific proteins. Threonine's role in lipotropic function helps control fat build-up in the liver and enhances nutrient absorption.
Pharmacodynamics
L-Threonine is essential for maintaining proper protein balance in the body. It supports the synthesis of critical structural proteins and plays a role in metabolic functions related to liver health. Threonine also aids in the formation of collagen and elastin, which are vital for skin and connective tissue integrity.
Pharmacokinetics
Threonine is absorbed in the intestines and utilized by various tissues throughout the body. As an essential amino acid, it cannot be synthesized by the body and must be obtained from dietary sources. Once absorbed, threonine is incorporated into proteins or converted into other metabolites as needed for various physiological functions.
Pregnancy
Threonine is generally considered safe during pregnancy as it is an essential amino acid required for fetal development.
Breast-feeding
Threonine is also considered safe during breastfeeding, as it is essential for protein synthesis and overall growth in infants.
Storage
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: valine
BNF-referencedValine is an essential branched-chain amino acid (BCAA) vital for various physiological functions. It cannot be synthesized by the human body and must be obtained through dietary sources. Valine plays a crucial role in muscle metabolism, tissue repair, and energy production. It is also involved in the stimulation of growth hormone production and the regulation of blood sugar levels. Given its importance, deficiencies in valine can lead to growth impairment, neuropathy, and anemia.
Indications
- Supplementation for muscle growth and recovery
- Support in exercise and athletic performance
- Management of deficiencies in essential amino acids
- Potential support in metabolic disorders related to BCAA catabolism
Dosage
Children: Refer to the BNF for Children for
Adults: Refer to the BNF for specific dosing recommendations, as dosages can vary based on the condition being treated and the formulation used.
Mechanism of action
Valine's catabolism begins in muscle tissue, where it undergoes transamination catalyzed by a single branched-chain amino acid aminotransferase. The process yields different alpha-keto acids that are further oxidized by branched-chain alpha-keto acid dehydrogenase to produce CoA derivatives, with propionyl-CoA being the principal product. This pathway concludes with the generation of metabolic intermediates essential for energy production and biosynthesis.
Pharmacodynamics
L-valine exhibits stimulant activity that supports muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway and has been shown to enhance energy levels, increase endurance, and facilitate muscle recovery. Valine is necessary for optimal growth in infants and children, and it helps maintain nitrogen balance in adults. Supplementation is recommended in conjunction with isoleucine and leucine in a 2:1:2 ratio for maximum efficacy.
Pharmacokinetics
Valine is absorbed in the gastrointestinal tract and its bioavailability is influenced by dietary factors and the presence of other amino acids. The metabolism of valine primarily occurs in skeletal muscle, where it is catabolized to yield energy. Valine is incorporated into proteins during translation and is excreted primarily in the urine as part of metabolic waste. The half-life and elimination of valine are not extensively documented due to its classification as an amino acid rather than a conventional drug.
Adverse effects
- Neuropathic obstacles
- Anaemia
Precautions
- Supplemental valine should be combined with isoleucine and leucine at a respective milligram ratio of 2:1:2.
Pregnancy
Valine is an essential amino acid necessary for fetal development, but supplementation should be monitored.
Breast-feeding
Valine is present in breast milk and is important for infant growth; however, excessive supplementation should be avoided.
Storage
Store in a cool, dry place away from direct sunlight.
Formulations
- Powder
- Capsules
- Tablets
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: Glycine
PubChem CID 750Molecular formula: C2H5NO2
Mechanism of action
In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS. HYPERPOLARIZATION OF MOTONEURONS PRODUCED BY IONTOPHORETIC APPLICATION OF GLYCINE IS RELATIVELY TRANSIENT BUT APPROACHES THE EQUILIBRIUM POTENTIAL FOR THE INDIRECTLY ACTIVATED INHIBITORY POSTSYNAPTIC POTENTIAL...TESTS WITH GABA... INDICATE SIMILAR ELECTROPHYSIOLOGICAL EFFECTS & SIMILAR INCR IN CL- CONDUCTANCE. MAJOR EVIDENCE THAT FAVORS GLYCINE AS MEDIATOR OF INTRASPINAL POSTSYNAPTIC INHIBITION IS THE SELECTIVE ANTAGONISM OF ITS EFFECTS BY STRYCHNINE. ... GLYCINE ALSO APPEARS TO BE MOST LIKELY TRANSMITTER FOR INHIBITORY INTERNEURONS IN RETICULAR FORMATION BUT NOT IN CUNEATE NUCLEUS.
Pharmacodynamics
Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
Molecular reference: methionine
PubChem CID 6137Molecular formula: C5H11NO2S
Mechanism of action
The mechanism of the possible anti-hepatotoxic activity of L-methionine is not entirely clear. It is thought that metabolism of high doses of acetaminophen in the liver lead to decreased levels of hepatic glutathione and increased oxidative stress. L-methionine is a precursor to L-cysteine. L-cysteine itself may have antioxidant activity. L-cysteine is also a precursor to the antioxidant glutathione. Antioxidant activity of L-methionine and metabolites of L-methionine appear to account for its possible anti-hepatotoxic activity. Recent research suggests that methionine itself has free-radical scavenging activity by virtue of its sulfur, as well as its chelating ability. Amino acids are selected for protein synthesis by binding with transfer RNA (tRNA) in the cell cytoplasm. The information on the amino acid sequence of each individual protein is contained in the sequence of nucleotides in the messenger RNA (mRNA) molecules, which are synthesized in the nucleus from regions of DNA by the process of transcription. The mRNA molecules then interact with various tRNA molecules attached to specific amino acids in the cytoplasm to synthesize the specific protein by linking together individual amino acids; this process, known as translation, is regulated by amino acids (e.g., leucine), and hormones. Which specific proteins are expressed in any particular cell and the relative rates at which the different cellular proteins are synthesized, are determined by the relative abundances of the different mRNAs and the availability of specific tRNA-amino acid combinations, and hence by the rate of transcription and the stability of the messages. From a nutritional and metabolic point of view, it is important to recognize that protein synthesis is a continuing process that takes place in most cells of the body. In a steady state, when neither net growth nor protein loss is occurring, protein synthesis is balanced by an equal amount of protein degradation. The major consequence of inadequate protein intakes, or diets low or lacking in specific indispensable amino acids relative to other amino acids (often termed limiting amino acids), is a shift in this balance so that rates of synthesis of some body proteins decrease while protein degradation continues, thus providing an endogenous source of those amino acids most in need. /Protein synthesis/ The mechanism of intracellular protein degradation, by which protein is hydrolyzed to free amino acids, is more complex and is not as well characterized at the mechanistic level as that of synthesis. A wide variety of different enzymes that are capable of splitting peptide bonds are present in cells. However, the bulk of cellular proteolysis seems to be shared between two multienzyme systems: the lysosomal and proteasomal systems. The lysosome is a membrane-enclosed vesicle inside the cell that contains a variety of proteolytic enzymes and operates mostly at acid pH. Volumes of the cytoplasm are engulfed (autophagy) and are then subjected to the action of the protease enzymes at high concentration. This system is thought to be relatively unselective in most cases, although it can also degrade specific intracellular proteins. The system is highly regulated by hormones such as insulin and glucocorticoids, and by amino acids. The second system is the ATP-dependent ubiquitin-proteasome system, which is present in the cytoplasm. The first step is to join molecules of ubiquitin, a basic 76-amino acid peptide, to lysine residues in the target protein. Several enzymes are involved in this process, which selectively targets proteins for degradation by a second component, the proteasome. /Protein degradation/ Methionine dependence, the inability of cells to grow when the amino acid methionine is replaced in culture medium by its metabolic precursor homocysteine, is characteristic of many cancer cell lines and some tumors in situ. Most cell lines proliferate normally under these conditions. The methionine dependent t
Pharmacodynamics
L-Methionine is a principle supplier of sulfur which prevents disorders of the hair, skin and nails; helps lower cholesterol levels by increasing the liver's production of lecithin; reduces liver fat and protects the kidneys; a natural chelating agent for heavy metals; regulates the formation of ammonia and creates ammonia-free urine which reduces bladder irritation; influences hair follicles and promotes hair growth. L-methionine may protect against the toxic effects of hepatotoxins, such as acetaminophen. Methionine may have antioxidant activity.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
Molecular reference: phenylalanine
PubChem CID 6140Molecular formula: C9H11NO2
Mechanism of action
The supposed antidepressant effects of L-phenylalanine may be due to its role as a precursor in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain norepinephrine and dopamine levels are thought to be associated with antidepressant effects. The mechanism of L-phenylalanine's possible antivitiligo activity is not well understood. It is thought that L-phenylalanine may stimulate the production of melanin in the affected skin Amino acids are selected for protein synthesis by binding with transfer RNA (tRNA) in the cell cytoplasm. The information on the amino acid sequence of each individual protein is contained in the sequence of nucleotides in the messenger RNA (mRNA) molecules, which are synthesized in the nucleus from regions of DNA by the process of transcription. The mRNA molecules then interact with various tRNA molecules attached to specific amino acids in the cytoplasm to synthesize the specific protein by linking together individual amino acids; this process, known as translation, is regulated by amino acids (e.g., leucine), and hormones. Which specific proteins are expressed in any particular cell and the relative rates at which the different cellular proteins are synthesized, are determined by the relative abundances of the different mRNAs and the availability of specific tRNA-amino acid combinations, and hence by the rate of transcription and the stability of the messages. From a nutritional and metabolic point of view, it is important to recognize that protein synthesis is a continuing process that takes place in most cells of the body. In a steady state, when neither net growth nor protein loss is occurring, protein synthesis is balanced by an equal amount of protein degradation. The major consequence of inadequate protein intakes, or diets low or lacking in specific indispensable amino acids relative to other amino acids (often termed limiting amino acids), is a shift in this balance so that rates of synthesis of some body proteins decrease while protein degradation continues, thus providing an endogenous source of those amino acids most in need. /Amino acids/ The mechanism of intracellular protein degradation, by which protein is hydrolyzed to free amino acids, is more complex and is not as well characterized at the mechanistic level as that of synthesis. A wide variety of different enzymes that are capable of splitting peptide bonds are present in cells. However, the bulk of cellular proteolysis seems to be shared between two multienzyme systems: the lysosomal and proteasomal systems. The lysosome is a membrane-enclosed vesicle inside the cell that contains a variety of proteolytic enzymes and operates mostly at acid pH. Volumes of the cytoplasm are engulfed (autophagy) and are then subjected to the action of the protease enzymes at high concentration. This system is thought to be relatively unselective in most cases, although it can also degrade specific intracellular proteins. The system is highly regulated by hormones such as insulin and glucocorticoids, and by amino acids. The second system is the ATP-dependent ubiquitin-proteasome system, which is present in the cytoplasm. The first step is to join molecules of ubiquitin, a basic 76-amino acid peptide, to lysine residues in the target protein. Several enzymes are involved in this process, which selectively targets proteins for degradation by a second component, the proteasome. /Amino acids/
Pharmacodynamics
Used by the brain to produce Norepinephrine, a chemical that transmits signals between nerve cells and the brain; keeps you awake and alert; reduces hunger pains; functions as an antidepressant and helps improve memory.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
Molecular reference: threonine
PubChem CID 6288Molecular formula: C4H9NO3
Mechanism of action
L-Threonine is a precursor to the amino acids glycine and serine. It acts as a lipotropic in controlling fat build-up in the liver. May help combat mental illness and may be very useful in indigestion and intestinal malfunctions. Also, threonine prevents excessive liver fat. Nutrients are more readily absorbed when threonine is present. Amino acids are selected for protein synthesis by binding with transfer RNA (tRNA) in the cell cytoplasm. The information on the amino acid sequence of each individual protein is contained in the sequence of nucleotides in the messenger RNA (mRNA) molecules, which are synthesized in the nucleus from regions of DNA by the process of transcription. The mRNA molecules then interact with various tRNA molecules attached to specific amino acids in the cytoplasm to synthesize the specific protein by linking together individual amino acids; this process, known as translation, is regulated by amino acids (e.g., leucine), and hormones. Which specific proteins are expressed in any particular cell and the relative rates at which the different cellular proteins are synthesized, are determined by the relative abundances of the different mRNAs and the availability of specific tRNA-amino acid combinations, and hence by the rate of transcription and the stability of the messages. From a nutritional and metabolic point of view, it is important to recognize that protein synthesis is a continuing process that takes place in most cells of the body. In a steady state, when neither net growth nor protein loss is occurring, protein synthesis is balanced by an equal amount of protein degradation. The major consequence of inadequate protein intakes, or diets low or lacking in specific indispensable amino acids relative to other amino acids (often termed limiting amino acids), is a shift in this balance so that rates of synthesis of some body proteins decrease while protein degradation continues, thus providing an endogenous source of those amino acids most in need. /Protein synthesis/ The mechanism of intracellular protein degradation, by which protein is hydrolyzed to free amino acids, is more complex and is not as well characterized at the mechanistic level as that of synthesis. A wide variety of different enzymes that are capable of splitting peptide bonds are present in cells. However, the bulk of cellular proteolysis seems to be shared between two multienzyme systems: the lysosomal and proteasomal systems. The lysosome is a membrane-enclosed vesicle inside the cell that contains a variety of proteolytic enzymes and operates mostly at acid pH. Volumes of the cytoplasm are engulfed (autophagy) and are then subjected to the action of the protease enzymes at high concentration. This system is thought to be relatively unselective in most cases, although it can also degrade specific intracellular proteins. The system is highly regulated by hormones such as insulin and glucocorticoids, and by amino acids. The second system is the ATP-dependent ubiquitin-proteasome system, which is present in the cytoplasm. The first step is to join molecules of ubiquitin, a basic 76-amino acid peptide, to lysine residues in the target protein. Several enzymes are involved in this process, which selectively targets proteins for degradation by a second component, the proteasome. /Protein degradation/
Pharmacodynamics
L-Threonine is an essential amino acid that helps to maintain the proper protein balance in the body. It is important for the formation of collagen, elastin, and tooth enamel, and aids liver and lipotropic function when combined with aspartic acid and methionine.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
Molecular reference: valine
PubChem CID 6287Molecular formula: C5H11NO2
Mechanism of action
(Applies to Valine, Leucine and Isoleucine) This group of essential amino acids are identified as the branched-chain amino acids, BCAAs. Because this arrangement of carbon atoms cannot be made by humans, these amino acids are an essential element in the diet. The catabolism of all three compounds initiates in muscle and yields NADH and FADH2 which can be utilized for ATP generation. The catabolism of all three of these amino acids uses the same enzymes in the first two steps. The first step in each case is a transamination using a single BCAA aminotransferase, with a-ketoglutarate as amine acceptor. As a result, three different a-keto acids are produced and are oxidized using a common branched-chain a-keto acid dehydrogenase, yielding the three different CoA derivatives. Subsequently the metabolic pathways diverge, producing many intermediates. The principal product from valine is propionylCoA, the glucogenic precursor of succinyl-CoA. Isoleucine catabolism terminates with production of acetylCoA and propionylCoA; thus isoleucine is both glucogenic and ketogenic. Leucine gives rise to acetylCoA and acetoacetylCoA, and is thus classified as strictly ketogenic. There are a number of genetic diseases associated with faulty catabolism of the BCAAs. The most common defect is in the branched-chain a-keto acid dehydrogenase. Since there is only one dehydrogenase enzyme for all three amino acids, all three a-keto acids accumulate and are excreted in the urine. The disease is known as Maple syrup urine disease because of the characteristic odor of the urine in afflicted individuals. Mental retardation in these cases is extensive. Unfortunately, since these are essential amino acids, they cannot be heavily restricted in the diet; ultimately, the life of afflicted individuals is short and development is abnormal The main neurological problems are due to poor formation of myelin in the CNS. Amino acids are selected for protein synthesis by binding with transfer RNA (tRNA) in the cell cytoplasm. The information on the amino acid sequence of each individual protein is contained in the sequence of nucleotides in the messenger RNA (mRNA) molecules, which are synthesized in the nucleus from regions of DNA by the process of transcription. The mRNA molecules then interact with various tRNA molecules attached to specific amino acids in the cytoplasm to synthesize the specific protein by linking together individual amino acids; this process, known as translation, is regulated by amino acids (e.g., leucine), and hormones. Which specific proteins are expressed in any particular cell and the relative rates at which the different cellular proteins are synthesized, are determined by the relative abundances of the different mRNAs and the availability of specific tRNA-amino acid combinations, and hence by the rate of transcription and the stability of the messages. From a nutritional and metabolic point of view, it is important to recognize that protein synthesis is a continuing process that takes place in most cells of the body. In a steady state, when neither net growth nor protein loss is occurring, protein synthesis is balanced by an equal amount of protein degradation. The major consequence of inadequate protein intakes, or diets low or lacking in specific indispensable amino acids relative to other amino acids (often termed limiting amino acids), is a shift in this balance so that rates of synthesis of some body proteins decrease while protein degradation continues, thus providing an endogenous source of those amino acids most in need. /Amino acids/ The mechanism of intracellular protein degradation, by which protein is hydrolyzed to free amino acids, is more complex and is not as well characterized at the mechanistic level as that of synthesis. A wide variety of different enzymes that are capable of splitting peptide bonds are present in cells. However, the bulk of cellular proteolysis seems to be shared between two multienzyme systems: the lysoso
Pharmacodynamics
L-valine is a branched-chain essential amino acid (BCAA) that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway. Valine is one of three branched-chain amino acids (the others are leucine and isoleucine) that enhance energy, increase endurance, and aid in muscle tissue recovery and repair. This group also lowers elevated blood sugar levels and increases growth hormone production. Supplemental valine should always be combined with isoleucine and leucine at a respective milligram ratio of 2:1:2. It is an essential amino acid found in proteins; important for optimal growth in infants and for growth in children and nitrogen balance in adults. The lack of L-valine may influence the growth of body, cause neuropathic obstacle, anaemia. It has wide applications in the field of pharmaceutical and food industry.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- (L-Isoleucine /L-Leucine / L-Lysine Hydrochloride/ L-Methionine / L-Phenylalanine / L-Threonine / L-Tryptophan /L-Valine /L-Arginine / L-Histidine / Glycine / L-Alanine / L-Proline / L-Aspartic Acid / L-Asparagine H2O/L-Cysteine Hydrochloride · Otsuka Pharmaceutical
- 1.5% GLYCINE IRRIGATION FLUID(INTRAFLEX) INFUSION (Each ml contains Glycine 1.5%w/v) · Intravenous Infusions
- AMINOVIT ORAL SOLUTION · Saudi Pharmaceutical Industries
- AMINOVITALYTE WATER SOLUBLE POWDER (Each 1000gram contains: Vitamin A 13,500,000iu/ Vitamin D3 4,150,000iu/ Vitamin E 3750mg/ Vitamin K 4500mg/ Vitamin B2 4,500mg/ Vitamin B6 3000mg/ Vitamin B12 11,500mcg/ Vitamin C 5,000mg/ Biotin 50mcg/ Folic Acid 1,000mg/ Niacin 16,750mg/ Citric Acid 10,000mg/ Glutamic Acid 1660mg/ Proline 4,800mg/ Threonine 52,500mg/ Glycine 3820mg/ L-Lysine 16,000mg/ DL-Methionine 12,000mg/ D-Calcium Pantothenate 8000mg/ Dicalcium Phosphate 10,000mg/ Magnesium Sulphate 4000mg/ Manganese Sulphate 4000mg/ Copper Sulphate 7500mg/ Zinc Sulphate 1500mg/ Iron Sulphate 5000mg/ Sodium Chloride 50,000mg/ Potassium Chloride 88,000mg/ Sodium Selenite 50mg/ Probiotics(Lactic Acid Baccillus ) 5,000,000CFU) · Osamed Green Solution
- ASTYFER CAPSULES · Til Healthcare
- ASTYFER LIQUID SYRUP ( Ferrous Glycine Sulphate/ L-Histidine Hydrochloride Monohydrate/ L-Lysine Hydrochloride/ Thiamine Hydrochloride/ Riboflavin/ Pyridoxine Hydrochloride/ Nicotinamide/ D-Panthenol/ Cyanocobalamin/ Folic acid 275mg/4mg/25mg/5mg/3mg/1.5mg/25mg/2.5mg/2.5mcg/0.5mg) · Til Healthcare
- Celemin 10 Plus · Otsuka Pharmaceutical
- FAROPLAV 75 · Acme Laboratories
- FAROPLAV-A 75/75 · Acme Laboratories
- Fecontin-F · Modi-mundipharma
- LH-IMIDOCARB · Hebei Lihua Pharmaceutical Co., Ltd
- LH-IMIDOCARB Injection 12% · Hebei Lihua Pharmaceutical
- ASTYMIN-3 · Til Healthcare
- Broiler Boost Multivitamin · Kela
- Cibus Vitaphos Biomin Oral Powder · Vetcare Kenya
- EGG-BOOST Oral Powder · Teleios Pharma
- Golden Vita Powder · Hebei New Century Pharmaceutical
- Introvit Injection · Interchemie Werken De Adelaar
- POLINUTHREE EN-1000 AMINO ACID SOLUTION WITH ELETROLYTES,GLUCOSE SOLUTION AND LIPID EMULSION · Polifarma Ilac San. Vetic. A.s. , Vakiflar Osb Mahallesi, Sanayi Caddesi
- POLINUTHREE EN-550 WITH ELECTROLYTES, GLUCOSE SOLUTION AND LIPID EMULSION · Polifarma Ilac San. Vetic. A.s. , Vakiflar Osb Mahallesi, Sanayi Caddesi